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Type I collagen (Col I)-stimulated matrix metalloproteinase-2
(MMP-2) activation via membrane type 1 MMP (MT1-MMP)
involves both a transcriptional increase in MT1-MMP expression
and a nontranscriptional response mediated by preexisting MT1-
MMP. In order to identify which MT1-MMP domains were
required for the nontranscriptional response, MCF-7 cells that lack
endogenous MT1-MMP were transfected with either wild type or
domain mutant MT1-MMP constructs. We observed that mutant
constructs lacking theMT1-MMPcytoplasmic tailwere able to acti-
vate MMP-2 in response to Col I but not a construct lacking the
MT1-MMPhemopexin domain. Col I did not alter totalMT1-MMP
protein levels; nor did it appear to directly induce MT1-MMP oli-
gomerization. Col I did, however, redistribute preexisting MT1-
MMP to the cell periphery compared with unstimulated cells that
displayed amore diffuse staining pattern. In addition, Col I blocked
the internalization of MT1-MMP in a dynamin-dependent manner
via clathrin-coated pit-mediated endocytosis. This mechanism of
impaired internalization is different from that reported for con-
canavalin A, since it is notmediated by the cytoplasmic tail ofMT1-
MMP but rather by the hemopexin domain. In summary, upon Col
I binding to its cell surface receptor, MT1-MMP internalization via
clathrin-coated pit-mediated endocytosis is impaired through
interactions with the hemopexin domain, thereby regulating its
function and ability to activate MMP-2.
Matrixmetalloproteinases (MMPs)2 are a family of zinc-binding, cal-
cium-dependent proteolytic enzymes with the ability to remodel the
extracellular matrix (ECM) as well as cleave a number of cell surface
modulators (1). Due to their ability to influence a plethora of cell func-
tions, aberrantMMP activity has been associatedwith several patholog-
ical situations such as rheumatoid arthritis, diabetic nephropathy,
angiogenesis, and tumor invasion and metastasis (2, 3). Although sev-
eral MMPs have been associated with tumor progression, particular
attention has been focused onMMP-2 andMT1-MMP, which are often
produced by peritumoral fibroblasts within a tumor (4, 5). MT1-MMP
can break down a variety of extracellular proteins, including collagens
type I, II, and III, fibronectin, vitronectin, laminin, fibrin, and proteogly-
cans, as well as modulating cell function by processing a number of
non-ECM proteins (6–9). An important role of several of the MT-
MMPs (MT1-, MT2-, MT3-, MT5-, and MT6-MMP) is the cell-local-
ized activation of pro-MMP-2 (10). MT1-MMP is also a key enzyme
involved in cell migration and invasion and has been localized to the
leading edge of migrating cells, thus facilitating matrix remodeling (7,
11). MT1-MMP null mice display abnormal development and aberrant
collagen degradation and die prematurely due to these defects (12, 13).
Although unchallenged MMP-2 null mice appear healthy, double
knock-out MMP-2/MT1-MMP null mice show a more severe pheno-
type compared with the single MT1-MMP null mice, since the double
null mice die within minutes of birth (14). This important observation
highlights the cooperativity of MMP-2 andMT1-MMP in vivo, indicat-
ing that both enzymes have unique and overlapping functions.
MMP-2 activation proceeds on the cell surface in a two-step process
involving a trimolecular complex ofMT1-MMP, tissue inhibitor ofmet-
alloproteinases-2, and MMP-2. The initial cleavage of the pro-domain
of MMP-2 is mediated by the membrane-tethered MT1-MMP, gener-
ating an intermediate form of MMP-2 (15–17). The remainder of the
propeptide is removed by an autocatalytic mechanism generating the
fully active enzyme (18, 19). In addition to regulation by gene transcrip-
tion, zymogen activation, and inhibition by tissue inhibitors of metallo-
proteinases, MT1-MMP activity can be regulated by complex events,
including autocatalytic processing, ectodomain shedding, differential
glycosylation (20), homodimerization via the HPX domain (21) or cyto-
plasmic tail of MT1-MMP (22, 23), microdomain compartmentaliza-
tion, and internalization involving both clathrin-dependent and -inde-
pendent mechanisms (24–26). The regulation of internalization of
MT1-MMP has been postulated as a rapid short term level of control of
net MT1-MMP proteolytic activity on the cell surface.
Primary fibroblasts grown in three-dimensional fibrillar collagen gels
have previously been shown to activate MMP-2 (27, 28). This has also
been extended to other cell types, such as endothelial cells and tumor
cell lines such as HT1080, MDA-MB-231, and BT549 cells (29–31).
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Type I collagen (Col I)-stimulated MMP-2 activation functions princi-
pally viaMT1-MMP in fibroblasts, since noMMP-2 activation occurs in
MT1-MMP-deficient mouse fibroblasts in response to Col I (27), and
reduced levels of active MMP-2 are seen in MT1-MMP-deficient mice
(12). Col I can activate MMP-2 through 2 distinct mechanisms. First,
Col I can increase MT1-MMP mRNA and protein levels, thereby acti-
vating MMP-2 (transcriptional response). Indeed, endothelial cells cul-
tured in a three-dimensional Col I matrix induced MT1-MMP expres-
sion, which was dependent on the Egr-1 site in the MT1-MMP
promoter (32). Col I induction of MT1-MMP mRNA also appeared to
be dependent on Rac1 function in HT1080 cells (33). Furthermore,
treatment of HT1080 cells with Col I induced MT1-MMP-dependent
extracellular signal-regulated kinase activation, which in turn increased
MT1-MMP protein levels and cell migration (31). However, an alter-
nate pathway has been observed in which Col I increases the activity of
preexisting MT1-MMP molecules in order to activate MMP-2 (non-
transcriptional response) (34, 35). Due to the importance ofMT1-MMP
and MMP-2 in several pathological conditions, including tumor inva-
sion and metastasis, we aimed to study the nontranscriptional mecha-
nism of MMP-2 activation via MT1-MMP induced by Col I, the latter
being abundant in the tissue stroma. We determined that Col I blocks
MT1-MMP internalization through a clathrin-coated pit-mediated
mechanism involving the MT1-MMP hemopexin domain, thereby
stimulating MMP-2 activation.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—MCF-7-MT1-MMP cells (36) were
generated by stably transfectingMT1-MMPcDNAunder the control of
the cytomegalovirus promoter (pCNCMT1-MMP) into an MCF-7
clone previously transfected with -galactosidase and maintained in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with
10% (v/v) fetal bovine serum (JRH Biosciences, Lenexa, KS). BT549
breast adenocarcinoma cells were obtained from the ATCC (Manassas,
VA) and maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% (v/v) fetal bovine serum. Human breast fibroblasts
were isolated from human breast tissue with appropriate consent from
women undergoing reduction mammoplasty in accordance with the
standards of the St. Vincent’s Hospital Human Ethics Committee. Tis-
sue wasminced and digested with 200 units/ml collagenase (Sigma) and
100 units/ml hyaluronidase (Sigma) in Dulbecco’s modified Eagle’s
medium/F-12 with 10% (v/v) fetal bovine serum and penicillin/strepto-
mycin/amphoporicin B (Invitrogen) overnight at 37 °C and 5% CO2
with gentle rocking. Digested tissue was centrifuged at 600  g for 10
min, and the cell pellet was resuspended inmediumand filtered through
a 40-m cell strainer. The cells were allowed to attach overnight, cul-
tured in growth medium as above, and used within 3 passages.
For transfection experiments, cells were plated in 6-well plates (3 
105 cells/well) and transfected with FuGENE 6 (Roche Applied Science)
in serum-containing medium as per the manufacturer’s instructions
using 2 g of plasmid DNA with 6 l of FuGENE per treatment.
Plasmids and Reagents—Wild-type MT1-MMP and mutant con-
structs (Fig. 1) were generated as previously described (21, 37, 38):
briefly, wtMT1-MMP (wild typeMT1-MMP), MT1-CT (MT1-MMP
lacking the cytoplasmic tail (Met1–Val559)),MT1-IL2R (the ectodomain
of MT1-MMP (Met1–Gly535) with the TM/CT of the interleukin 2
receptor  (Val239–Ile270)), MT1-NGFR (the ectodomain of MT1-
MMP (Met1–Asp515) with the TM/CT of the NGFR (neurotrophic
tyrosine kinase receptor type I, NTRK1) that possesses an intrinsic
kinase domain (Glu384–Gly790)), MT1-CAT (MT1-MMP lacking the
catalytic domain (Tyr112–Pro312)), and MT1-HPX (MT1-MMP
lacking the HPX domain (Ile318–Gly535)). All constructs include the
FLAG epitope, Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys, in the catalytic
domain as described (21). MT1-HPX, wild type dynamin, and K44A
dominant-negative dynamin were a kind gift from Dr. Duanqing Pei
(University of Minnesota School of Medicine, Minneapolis, MN).
Eps1595/295 in pEGFP vector was kindly provided by Dr. Alexandre
Benmerah (Faculte´ Necker-EnfantsMalades, Paris, France) andDr. Jen-
nifer Stow (Institute for Molecular Bioscience, University of Queens-
land, Brisbane, Australia).
Recombinant pro-MMP-2 expressed in vaccinia virus (rMMP-2) was
a kind gift from Dr. Rafael Fridman (Wayne State University, Detroit,
MI). Concanavalin A (ConA), nystatin, methyl--cyclodextrin, cyclo-
heximide, gelatin-agarose beads, and protein G-agarose beads were
purchased from Sigma. Vitrogen 100 Col I was obtained fromCohesion
(Palo Alto, CA). Sulfo-NHS-LC-biotin was obtained from Pierce. Anti-
phosphotyrosine monoclonal antibody (P-Tyr-100) was purchased
from Cell Signaling Technologies (Beverly, MA). Nonspecific rabbit
IgG, ExtrAvidin-horseradish peroxidase, anti-FLAG M2 monoclonal
antibody, and FLAG peptide were purchased from Sigma.Mouse anti-
humanMT1-MMP antibody (clone 114-1F2) was purchased from Cal-
biochem, and rabbit anti-human polyclonal MT1-MMP antibody
(AB815) was obtained from Chemicon (Boronia, Australia). A rabbit
anti-human polyclonal MMP-2 antibody (PAB 753) was kindly pro-
vided by Dr. Jack Windsor (University of Alabama at Birmingham).
Horseradish peroxidase-conjugated secondary antibodies were
obtained from Pierce. Alexa Fluor 568-labeled transferrin and donkey
anti-rabbit secondary Alexa Fluor 488-conjugated antibody were
obtained fromMolecular Probes, Inc. (Eugene, OR). IRDye700DX-con-
jugated purified anti-rabbit antibody was obtained from Rockland
Immunochemicals (Gilbertsville, PA). ODYSSEY infrared imaging sys-
tem blocking buffer was purchased from LI-COR Biosciences (Lincoln,
NE).
Cell Lysates for Western Blot Analysis—Cells were washed twice in
PBS and lysed with 1.5% (v/v) chilled Triton X-114 in Tris-buffered
saline (10 mM Tris, pH 8.0, 150 mM NaCl) with EDTA-free complete
protease inhibitor mixture (Roche Applied Science). Samples were cen-
trifuged at top speed in a microcentrifuge for 15 min at 4 °C to remove
insolublematerial. Supernatants were then collected, placed at 37 °C for
5 min, and centrifuged at top speed in a microcentrifuge at room tem-
perature. The bottom detergent phase containing cell membranes was
then collected.
Cell Lysates for Immunoprecipitation—Cells were washed twice in
PBS, and the cells were harvested in fresh chilled PBS with a rubber cell
scraper. The cell/PBS mixture was then transferred to 1.5-ml tubes and
centrifuged at 3000 g for 10 min at 4 °C to pellet the cells. The super-
natant was then removed, and the cells were resuspended in lysis buffer
(10 mM Tris-HCl, pH 7.6, 10 mM NaCl, 3 mM MgCl2, 1% (v/v) Igepal
CA-630, EDTA-free complete protease inhibitor mixture, 1 mM NaF,
and 1 mM Na3VO4). Cells were left on ice for 1 h with periodic mixing,
followed by centrifugation at 3000 g for 10 min, and the supernatant
was collected.
MMP-2Capture—MMP-2 in the conditionedmediumof transfected
MCF-7 cells was captured with gelatin-agarose beads overnight at 4 °C.
Beads were then washed in 0.1% (v/v) TBS-Tween 20 and eluted with
SDS sample buffer.
MT1-MMP Immunoprecipitation—Equal amounts of protein lysates
(100 g) determined by a BCA protein quantification assay (Pierce)
were incubated with prewashed anti-FLAG M2-agarose beads over-
night at 4 °C on a rotating wheel. The next day, beads were pelleted by
gentle centrifugation, washed three times with Tris-buffered saline
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(TBS) and eluted with 200 g/ml FLAG peptide in TBS for 30 min at
4 °C. Equal amounts of eluted fractions were analyzed byWestern anal-
ysis for the presence of FLAG-tagged MT1-MMP or phosphorylated
MT1-NGFR.
Cell Surface Biotinylation—Transfected MCF-7 cells were cell sur-
face-biotinylated with 0.2 mg/ml sulfo-NHS-LC-biotin in PBS for 30
min at 4 °C. Cells were then washed in chilled PBS and neutralized with
0.1M glycine in PBS for 10min at 4 °C.Cells werewashed again in chilled
PBS and lysed as above for immunoprecipitation. Equal amounts of
lysates were precleared with protein G-agarose beads and 1 g of non-
specific rabbit IgG for 5 h at 4 °C. MT1-MMP molecules were then
immunoprecipitated with 1g of a rabbit anti-human polyclonalMT1-
MMP antibody (AB815) and protein G-agarose beads overnight at 4 °C.
Beads were then washed with lysis buffer and eluted with SDS sample
buffer.
RNA Isolation—RNA was harvested using RNeasy minicolumns
(Qiagen, CliftonHill, Australia). Quantification of RNAwas established
based on A260 nm and A280 nm using an ND-1000 spectrophotometer
(Nanodrop Technologies Inc., Rockland, DE).
Zymography—Conditioned medium was mixed with SDS sample
buffer (50 mM Tris-HCl, pH 6.8, 1% (w/v) SDS, 0.025% (w/v) bromphe-
nol blue, and 10% (v/v) glycerol) and separated on a 10% polyacrylamide
resolving gel co-polymerized with 1 mg/ml gelatin (BDH Laboratory
Supplies, Poole, UK). Zymogramswere thenwashed in 50mMTris-HCl,
5 mM CaCl2 (pH 8.0), and 2.5% (v/v) Triton X-100 overnight and then
incubated in 50mMTris-HCl, pH 7.5, 5mMCaCl2 for 24 h at 37 °C. Gels
were stainedwith 2.5mg/ml Coomassie Brilliant Blue (R250) dye in 10%
(v/v) acetic acid and 10% (v/v) isopropyl alcohol and then destained in
10% (v/v) acetic acid and 10% (v/v) isopropyl alcohol. Densitometry was
performed with the ODYSSEY program, version 1.2 (LI-COR
Biosciences).
Western Blot Analysis—Equal amounts of total protein from each
sample, determined by a BCA protein quantification assay, were pre-
pared in SDS sample buffer as above with 100 mM dithiothreitol and
boiled for 5 min. Protein samples were separated with a 10% polyacryl-
amide resolving gel. After electrophoresis, proteins were transferred to
a polyvinylidene difluoride membrane for 1 h at 100 V. Membranes
were then blocked in 5% (w/v) skim milk powder in 0.1% (v/v) TBS-
Tween 20 for 1 h at room temperature and probed either with a mouse
anti-human MT1-MMP antibody (clone 114-1F2; 1 g/ml), a rabbit
anti-human polyclonalMT1-MMP antibody (AB815; 1g/ml), an anti-
FLAG M2 monoclonal antibody (0.5 g/ml), or an anti-phosphoty-
rosine monoclonal antibody (P-Tyr-100; 0.5 g/ml) overnight at 4 °C.
Membranes were then washed in 0.1% (v/v) TBS-Tween 20 and probed
with a horseradish peroxidase-conjugated goat anti-mouse secondary
antibody for all monoclonal primary antibodies or a horseradish perox-
idase-conjugated donkey anti-rabbit secondary antibody for the poly-
clonal primary antibodies for 1 h at room temperature. Membranes
were washed in 0.1% (v/v) TBS-Tween 20, and detection of the second-
ary antibody was performed using the SuperSignal Chemiluminescent
Substrate system (Pierce). For cell surface biotinylation analysis, mem-
branes were blocked in 5% (w/v) BSA in 0.1% (v/v) TBS-Tween 20 for 30
min at room temperature and probedwith ExtrAvidin-horseradish per-
oxidase for 1 h at room temperature. In the case of theMMP-2Western
blot analysis, membranes were blocked for 1 h at room temperature
using ODYSSEY blocking buffer and probed with an MMP-2 antibody
(PAB 753; 10g/ml) overnight at 4 °C.Membraneswere thenwashed in
0.1% (v/v) TBS-Tween 20 and probed with IRDye700DX-conjugated
FIGURE 1. Wild type and chimeric MT1-MMP
constructs. Constructs are described under
“Experimental Procedures.”
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purified anti-rabbit antibody for 1 h at room temperature. Membranes
were washed in 0.1% (v/v) TBS-Tween 20, and detection was performed
using the fluorescence 700 channel on the ODYSSEY Infrared Imaging
System (LI-COR Biosciences). Densitometry was performed with the
ODYSSEY program, version 1.2.
cDNA Synthesis and Quantitative PCR—cDNA was prepared from
100 ng of total RNA. cDNA was generated with the Thermoscript RT-
PCR System (Invitrogen) using gene-specific priming with primer
5-CAGAAAACGTGCACATGAGCTGC-3 for human L32 and
primer 5-CAGCCAAGTGGCGGTAGGAT-3 for dynamin and an
annealing/extension temperature of 55 °C. Human ribosomal protein
L32 mRNA was used as a housekeeping gene to normalize all samples.
Quantitative RT-PCR was performed on an ABI Prism 5700 Sequence
Detection System (PerkinElmer Applied Biosystems, Scoresby, Austra-
lia) with cDNA generated from an equivalent of 2 ng of RNA in 10 mM
Tris-HCl, pH 8.0, 2.5 mM Mg(C2H3O2)2, 50 mM KCl, 200 M dNTPs, a
1:40,000 dilution of SYBR Green I (Molecular Probes), 1 g/ml 6-car-
boxy-X-rhodamine (Molecular Probes), 8% (v/v) Me2SO, 200 nM prim-
ers, and 0.625 units ofAmpliTaqGold polymerase (Applied Biosystems)
per 25-l reaction. PCR primers are as follows: human L32 forward
primer, 5-CAGGGTTCGTAGAAGATTCAAGGG-3; human L32
reverse primer, 5-CTTGGAGGAAACATTGTGAGCGATC-3; for-
ward rat dynamin primer, 5-CCGGGACATGCTTATGCAGTTT-3;
and reverse rat dynamin primer, 5-GGCGGCTGTGATATCCT-
TCTT-3. Reaction conditions were 95 °C for 10 min followed by 50
cycles of 95 °C for 15 s and 60 °C for 1 min. Melt curve analysis from 60
to 95 °C was performed at the end of each run as a quality control step.
The difference in average cycle threshold between L32 (housekeeping)
and dynamin was determined by quadruplicate readings for each sam-
ple, and the mean and S.D. were determined. Data were presented as
FIGURE 2. Transcriptional and nontranscriptional mechanisms ofMMP-2 activation. Conditionedmedia were collected from unstimulated or Col I-stimulated (100g/ml) cells
at the indicated time points and assessed by gelatin zymography for BT549 cells (A), primary human breast fibroblasts (B), and stably transfectedMCF-7-MT1-MMP cells (C).D, MCF-7
cells were transiently transfected with MT1-MMP and treated for several hours with cycloheximide to block new protein synthesis and then treated or not with Col I (100g/ml) for
a further 24 h. Conditionedmediawere collected and analyzedbygelatin zymography. E, MCF-7 cellswere transiently transfectedwithMT1-MMPor vector control and treated or not
with Col I (100g/ml) for 24 h. Conditionedmedia were collected, MMP-2 was captured using gelatin agarose beads, and elutions were analyzed byWestern blot for MMP-2. In the
case of A, C,D, and E, 100 ng/ml recombinant pro-MMP-2was added to the cultures. Pro-MMP-2 (pro), intermediate activeMMP-2 (inter), and fully activeMMP-2 (active) are indicated
by arrows. The percentage of active MMP-2 (active/total) calculated by densitometry is indicated below each lane.
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relative expression levels relative to wild type dynamin-transfected
MCF-7 cells.
Internalization Detection by Immunofluorescence—Transfected
MCF-7 cells were plated and stimulated as indicated on Teflon-printed
glass slides (ElectronMicroscopy Sciences, Ft.Washington, PA) at 37 °C
and 5%CO2.The following day, cells were equilibrated at 4 °C for 30min
and incubated with a rabbit anti-human polyclonal MT1-MMP anti-
body (AB815; 1g/ml) in serum-freemedium for 2 h at 4 °C or 25g/ml
Alexa Fluor 568-conjugated transferrin in serum-free medium for 30
min at 37 °C. Cells were then washed with chilled PBS to remove
unbound material and then untreated or treated with acetic acid (500
mM acetic acid, 150mMNaCl) for 10min at 4 °C to remove cell surface-
bound MT1-MMP or transferrin. This method has previously been
shown to be very effective at removing cell surface-bound antibody
without affecting the internalized antibody-antigen complex (25). In
addition, after incubation with the MT1-MMP antibody at 4 °C, some
cells were washed in chilled PBS and placed at 37 °C for the indicated
time periods to resume the internalization process of cell surface mol-
ecules. Cells were then treated or not with acetic acid as above and
washed with chilled PBS. Cells were fixed with 3% (w/v) paraformalde-
hyde/PBS for 20 min and blocked/permeabilized with 5% (w/v) BSA,
0.25% (v/v) Triton X-100, PBS for 30 min. Primary antibody was
detected with a donkey anti-rabbit secondary Alexa Fluor 488-conju-
gated antibody (4 g/ml) in 1% (w/v) BSA/PBS for 1 h at room temper-
ature. After several PBS washes, nuclei were stained with propidium
iodide (0.25mg/ml in 0.25% (v/v) Triton X-100, PBS, RNase) for 10min
at 37 °C for antibody-labeled cells. Cells were then washed in PBS,
mounted using fluorescent mounting medium (DAKO), in PBS,
mounted using and viewed by confocal microscopy (Bio-Rad MRC
1024). The percentage of internalized MT1-MMP at each time point
was determined by measuring the pixel intensity of internalized (acid-
treated) samples versus total MT1-MMP. Three representative fields
per sample were used for statistical analysis.
Immunofluorescence for the Detection of Cell Surface MT1-MMP—
After transfection with the indicated plasmids, MCF-7 cells were plated
on Teflon-printed glass slides overnight at 37 °C and 5% CO2. The fol-
lowing day, cells were equilibrated at 4 °C for 30min and incubatedwith
a rabbit anti-human polyclonal MT1-MMP antibody (AB815; 1 g/ml)
in serum-free medium for 2 h at 4 °C to label cell surface MT1-MMP
molecules only. Cells were washed with chilled PBS, fixed with 3% (w/v)
paraformaldehyde/PBS for 20 min at room temperature, and blocked
with 5% (w/v) BSA/PBS for 30min. Primary antibody was detected with
a donkey anti-rabbit secondary Alexa Fluor 488-conjugated antibody (4
g/ml) in 1% (w/v) BSA/PBS for 1 h at room temperature. After several
washes in PBS, nuclei were stained with propidium iodide (0.25 mg/ml
in 0.25% (v/v) Triton X-100, PBS, RNase) for 10min at 37 °C. Cells were
then washed in PBS and mounted using fluorescent mounting medium
and viewed by confocal microscopy.
RESULTS
Nontranscriptional Component of Col I-induced MMP-2 Activa-
tion—Aspreviouslymentioned, Col I can activateMMP-2 in several cell
types (27, 30, 35). In most of these cases, the MMP-2 activation in
response to Col I is largely mediated by transcriptional control of MT1-
MMP, since an increase at both the mRNA and protein levels is
observed for MT1-MMP in response to Col I. However, in addition, a
FIGURE 3. Effect of MT1-MMP TM/CT.MCF-7 cells were transiently transfected with vector control, wtMT1-MMP, or MT1-IL2R. The following day, cells were incubated for 24 h in
serum-free medium with 100 ng/ml rMMP-2 containing 100 g/ml Col I where indicated. A, conditioned media were analyzed by gelatin zymography for MMP-2 analysis; B, cell
lysateswere analyzedbyWesternblot forMT1-MMPusing the anticatalytic 114-1F2monoclonal antibody. Pro-MMP-2 (pro), intermediate activeMMP-2 (inter), and fully activeMMP-2
(active) are indicated by arrows. The percentage of activeMMP-2 (active/total) calculated by densitometry of gelatinolytic bands is indicated below each zymogram lane. MCF-7 cells
transfected with vector control (C), wtMT1-MMP (D), andMT1-IL2R (E) were analyzed 48 h after transfection by immunofluorescence for cell surface localization of MT1-MMP (green)
using the anti-hinge AB815 polyclonal antibody. Nuclei were stained with propidium iodide (red).
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nontranscriptional but post-translational component of Col I regula-
tion ofMT1-MMP activity has also been identified. The transcriptional
response is exemplified in Fig. 2, A and B, in BT549 cells and primary
human breast fibroblasts, respectively, which express endogenous
MT1-MMP that can be transcriptionally increased in response to Col I,
as previously reported (27, 35), resulting in increased MMP-2 activa-
tion, as seen by gelatin zymography. However, in MCF-7-MT1-MMP
cells (MCF-7 cells that lack endogenous MT1-MMP stably transfected
with MT1-MMP), Col I caused activation of MMP-2 despite MT1-
MMP being under the control of a heterologous promoter (Fig. 2C).
Similar results were also obtained by MMP-2 Western blot, although
the total amount of activation was lower using this method (Fig. 2E).
Furthermore, when MCF-7 cells transiently transfected with MT1-
MMP were treated with cycloheximide to block new protein synthesis,
some reduction in MMP-2 activation was seen, but the Col I response
was still observed (Fig. 2D). Thus, MCF-7-MT1-MMP cells provide a
model for nontranscriptional regulation of Col I-induced MMP-2
activation.
Col I-induced MMP-2 Activation Does Not Require the MT1-MMP
CT or HPXDomains—MCF-7 cells do not produceMT1-MMP protein
(Fig. 3, B andC) and do not activateMMP-2 in response to Col I, as seen
in Fig. 3A. Upon transfection of wtMT1-MMP, we observed MT1-
MMP protein by Western blot (Fig. 3B), which was localized to the cell
surface, as observed by immunofluorescence (Fig. 3D). MT1-MMP cell
surface localization was performed by antibody labeling of live, nonper-
meabilized cells at 4 °C, thus only detecting extracellular and not intra-
cellular or internalizedMT1-MMP. TheMT1-MMP produced renders
these cells capable of activating exogenous MMP-2 (Fig. 3A). After Col
I stimulation, we saw a further increase inMMP-2 activation, whichwas
not due to increased MT1-MMP protein levels (Fig. 3B) but rather to
Col I effects on MT1-MMP activity/localization. In order to determine
the contribution of the MT1-MMP transmembrane domain/cytoplas-
mic tail (TM/CT) on Col I-induced MMP-2 activation, we used an
MT1-MMP chimeric molecule composed of the CAT, hinge, and HPX
domains of MT1-MMP fused to the TM/CT of the interleukin-2
receptor (MT1-IL2R). The chimeric protein was expressed, albeit at
FIGURE4.Effectofdeletionmutants lackingMT1-MMPCATorHPXdomains.MCF-7 cellswere transiently transfectedwith vector control,wtMT1-MMP,MT1-HPX, orMT1-CAT.
The following day, cells were incubated for 24 h in serum-free media with 100 ng/ml rMMP-2 containing 100 g/ml Col I where indicated. A, conditioned media were analyzed by
gelatin zymography for MMP-2 analysis; B, cell lysates were analyzed by Western blot for MT1-MMP using the anti-FLAG M2 monoclonal antibody. Pro-MMP-2 (pro), intermediate
active MMP-2 (inter), and fully active MMP-2 (active) are indicated by arrows. The percentage of active MMP-2 (active/total) calculated by densitometry of gelatinolytic bands is
indicated below each zymogram lane. MCF-7 cells transfected with vector control (C), wtMT1-MMP (D), MT1-HPX (E), or MT1-CAT (F) were analyzed 48 h after transfection by
immunofluorescence for cell surface localization of MT1-MMP (green) using the AB815 polyclonal MT1-MMP antibody. Nuclei were stained with propidium iodide (red).
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lower levels than the wild type protein (Fig. 3B), and was localized to the
cell surface (Fig. 3E). Nevertheless, some basal MMP-2 activation was
observed with MT1-IL2R, and there was further activation in response
to Col I (Fig. 3A). We thus conclude that the TM/CT elements ofMT1-
MMP are not required for MMP-2 activation in response to Col I but
rather that Col I exerts its regulatory effects on the ectodomain of
MT1-MMP.
To study the extracellular domains of MT1-MMP, we used MT1-
MMP mutant constructs lacking either the CAT or HPX domains.
MT1-CAT lacking the CAT domain, although expressed (Fig. 4B) and
localized to the cell surface (Fig. 4F), was unable to activate MMP-2
under basal conditions or with Col I stimulation (Fig. 4A), as expected
due to the lack of a functional CAT domain. TheMT1-HPX construct
was also expressed (Fig. 4B) and localized to the cell surface (Fig. 4E) and
was able to activate MMP-2 under basal conditions (Fig. 4A), demon-
strating that this mutant was functional at least in terms of basal proc-
essing of MMP-2, as previously described (39). However, unlike
wtMT1-MMP or MT1-MMP lacking the TM/CT, the MT1-HPX
mutant could not further activateMMP-2 in response to Col I (Fig. 4A).
These results indicate that the Col I regulatory region lies in the HPX of
MT1-MMP.
Col I Does Not Appear to Directly IncreaseMT1-MMPClustering—It
has recently been reported that MT1-MMP forms homophilic interac-
tions on the cell surface via its HPX domains and that these dimeriza-
tions are required for MMP-2 activation (21, 22). We thus asked
whether Col-I increasedMT1-MMP dimerization. This was performed
using anMT1-NFGR construct that contains the CAT, hinge, and HPX
domains of MT1-MMP with the TM/CT of the NTRK1 nerve growth
factor receptor (NGFR) that contains an intrinsic kinase domain. It is
well established that growth factor receptors dimerize upon ligand
binding, causing autophosphorylation of the receptor (40). The MT1-
NFGR mutant has been shown to be autophosphorylated upon MT1-
MMP dimerization (21). When transfected into MCF-7 cells, MT1-
NFGR was expressed and localized to the cell surface similarly to
FIGURE 5.Col I does not appear to directly induceMT1-MMPclustering.MCF-7 cells were transiently transfectedwithwtMT1-MMPorMT1-NGFR, both ofwhich contain the FLAG
epitope in theCATdomain. The followingday, cellswere incubated for 24h in serum-freemediumwith100ng/ml rMMP-2 containing100g/mlCol Iwhere indicated.A, conditioned
medium were analyzed by gelatin zymography for MMP-2 activation analysis. Pro-MMP-2 (pro), intermediate active MMP-2 (inter), and fully active MMP-2 (active) are indicated by
arrows. The percentage of active MMP-2 (active/total) calculated by densitometry of gelatinolytic bands is indicated below each zymogram lane. MCF-7 cells transfected with
wtMT1-MMP (B) orMT1-NGFR (C)were analyzed48hafter transfectionby immunofluorescence for cell surface localizationofMT1-MMP (green) using theAB815polyclonalMT1-MMP
antibody. Nuclei were stained with propidium iodide (red). D and E, cell lysates were collected, and the FLAG-tagged MT1-MMP molecules were immunoprecipitated with an
anti-FLAGM2antibody.MT1-MMP-FLAGproteinswereelutedwithanexcessof theFLAGpeptide (200g/ml) and subjected toSDS-PAGE.Westernblot analysiswasperformedusing
an anti-FLAG antibody to detect total wtMT1-MMP orMT1-NGFR protein (B) or an anti-phosphotyrosine antibody to detect phosphorylatedMT1-NGFR (C). IP, immunoprecipitation;
WB, Western blot. Pro-MT1-MMP and active MT1-MMP have molecular masses of 63 and 60 kDa, respectively. MT1-NGFR runs at100 kDa.
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wtMT1-MMP (Fig. 5,C andB, respectively).MT1-NGFRwas also capa-
ble of activatingMMP-2, whichwas further increased in response toCol
I (Fig. 5A), similarly to MT1-IL2R. Whole cell lysates fromMCF-7 cells
transfected with wtMT1-MMP or MT1-NGFR (both tagged with the
FLAG epitope) were collected and immunoprecipitated with an anti-
FLAG antibody, and the eluted fractions were analyzed byWestern blot
probed with an anti-phosphotyrosine antibody to look for MT1-NGFR
transphosphorylation. No phosphotyrosine signal was detected in
wtMT1-MMP-transfected cells, as expected (Fig. 5E), despite theMT1-
MMP protein detected (Fig. 5D). However, tyrosine phosphorylation
was evident in MT1-NGFR-transfected cells, and the amount of phos-
phorylated MT1-NGFR was not further increased in response to Col I
(Fig. 5E), suggesting that Col I does not directly increase MT1-MMP
dimerization in our system. However, we cannot rule out the possibility
that the NGFR CT of the chimeric molecule interacts with other acces-
sory molecules that could be interfering with its ability to dimerize in
response to Col I.
Col I Blocks Dynamin-mediated MT1-MMP Internalization, Which
Differs from the Mechanism of ConA Inhibition of Internalization—Be-
cause Col I regulatedMT1-MMP activity rather than protein levels and
did not appear to directly affectMT1-MMPdimerization, we decided to
study Col I effects on MT1-MMP internalization, since this has been
recently identified as a mechanism that regulates MT1-MMP activity
post-translationally (25, 26, 41). First, MCF-7 cells transfected with
wtMT1-MMP, MT1-CT, MT1-IL2R, MT1-CAT, or MT1-HPX
were treated or not with Col I overnight. The amount of MT1-MMP
present on the cell surface was then determined by cell surface biotiny-
lation. An increase in cell surface MT1-MMP protein was observed
upon Col I stimulation for wtMT1-MMP, MT1-CT, MT1-IL2R, and
MT1-CAT. However, no increase in cell surfaceMT1-MMPwas seen
with theMT1-HPXmutant with Col I stimulation (Fig. 6,A (Western
blot) and B (densitometry of cell surface/total MT1-MMP)), consistent
with its inability to further activate MMP-2 in response to Col I.
Those MT1-MMP domains (CT and CAT) necessary for the ability
of Col I to increase cell surfaceMT1-MMPwere further studied using a
fluorescence-based internalization assay. MCF-7 cells transfected with
wtMT1-MMP, MT1-CT, or MT1-CAT and treated or not with Col
I were placed at 4 °C for 30 min to slow cellular events, including the
internalization process. The live cells were then incubated at 4 °C with
an anti-MT1-MMP antibody in order to label only cell surface MT1-
MMP molecules. The cells were then immediately fixed (time point 0
min) or warmed to 37 °C for 20 or 180 min to resume internalization.
Also, at each time point, the cells were either not treated or treated with
acetic acid in order to strip all cell surface antigen-antibody complexes
without interfering with internalized (intracellular) complexes. Fig. 7A
shows the cell surface staining for untreated andCol I-treated cells prior
to warming to 37 °C. Note that in Col I-treated cells, the localization of
MT1-MMP is concentrated around the edge of the cells, whereas in
untreated cells, MT1-MMP is more diffusely distributed on the cell
surface. This was consistently observed with wtMT1-MMP, MT1-
CT, and MT1-CAT. When treated with acetic acid, cell surface
staining was removed, and no internalizedMT1-MMPwas observed in
FIGURE 6. Cell surface biotinylation ofMT1-MMP.MCF-7 cells were transiently transfected with wtMT1-MMP, MT1-CT, MT1-CAT, MT1-IL2R, or MT1-HPX. A, the following day,
cells were incubated for 24 h in serum-free medium containing 100 g/ml Col I where indicated, after which cells were surface-biotinylated, and MT1-MMP molecules were
immunoprecipitated with the AB815 polyclonal MT1-MMP antibody and analyzed by Western blot probed with ExtrAvidin-horseradish peroxidase. B, densitometry of cell surface-
biotinylated bands was performed to determine the total amount of MT1-MMP present on the cell surface divided by the total MT1-MMP protein levels and plotted as -fold change
relative to the non-Col I-treated samples.
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all treatments (Fig. 7B). However, when cells were brought to 37 °C for
20 min to resume internalization, intracellular MT1-MMP was evident
in the acid-treated unstimulated cells; however, very little internalized
MT1-MMPwas detected inCol I-treated cells transfectedwithwtMT1-
MMP, MT1-CAT, or MT1-CT (Fig. 7B). A similar pattern was also
seen after 180min at 37 °C, althoughmore internalizedMT1-MMPwas
evident (Fig. 7B). ComparedwithwtMT1-MMPorMT1-CAT (which
showed similar internalization kinetics), MT1-CT showed very little
internalized MT1-MMP (Fig. 7B). This is in accordance with previous
studies showing reduced internalized MT1-CT, which lacks internal-
ization signals in the CT (25). However, the small amount of internal-
ized MT1-CT in the unstimulated cells was not seen in Col I-treated
cells (Fig. 7B). Taken together, these data clearly demonstrate that Col I
interferes with MT1-MMP internalization in MCF-7 cells, even when
lacking the CT or CAT domains but not the HPX domain.
MT1-MMP internalization has been identified to function by two
differentmechanisms: clathrin-coated pit-mediated internalization and
clathrin-independent mechanisms involving caveolae (24–26). For
clathrin-dependent MT1-MMP endocytosis, internalization signals
have been identified in theMT1-MMPCT (25).We thus further studied
the effect of Col I-induced MMP-2 activation using MT1-CT that
lacks the CT.We demonstrated usingMT1-IL2R andMT1-NGFR that
the TM/CT of MT1-MMP is not required for Col I-induced MMP-2
activation; however, these mutants contain a TM/CT of other proteins
that could interfere with the internalization process. Thus, to eliminate
any possible interference, we further studied Col I effects on MMP-2
activation using MT1-CT.
MCF-7 cells were transfected with wtMT1-MMP and MT1-CT,
both of which were localized to the cell surface (Fig. 8, D and E, respec-
tively). We observed in MT1-CT-transfected cells an increase in
MMP-2 activation compared with wtMT1-MMP (Fig. 8A) as predicted
based on its reduced internalization (25). An increase in the amount of
active MT1-MMP was also evident in cells transfected with MT1-CT
compared with wtMT1-MMP (Fig. 8B), consistent with an impairment
FIGURE7.Col IblocksMT1-MMPinternalization.
MCF-7 cells were transfected with wtMT1-MMP,
MT1-CT, or MT1-CAT. The following day, the
transfected cells were untreated or treated over-
night with 100 g/ml Col I. A, cells were then ana-
lyzed by immunofluorescence for cell surface
localization of MT1-MMP (green) using the anti-
hinge AB815 polyclonal antibody. Nuclei were
stained with propidium iodide (red). B, cells were
equilibrated at 4 °C for 30min to arrest cell surface
internalization and incubated with the AB815
polyclonal MT1-MMP antibody at 4 °C. Cells were
then untreated (for total MT1-MMP) or treated
with 500 mM acetic acid at 4 °C (for internalized
MT1-MMP) to remove cell surface-bound MT1-
MMP-antibody complexes. Cells were then
washed in PBS, fixed, permeabilized, and labeled
with a secondary Alexa Fluor 488 antibody. Alter-
natively, after incubation with the primary MT1-
MMP antibody, cells were washed in cold PBS and
placed at 37 °C for either 20 or 180 min, thereby
allowing internalization to resume. Cells were
then untreated or treated with 500 mM acetic acid
at 4 °C and then washed in PBS, fixed, permeabi-
lized, and labeledwitha secondaryAlexaFluor 488
antibody. The percentage of internalized MT1-
MMP at each time point was determined bymeas-
uring the pixel intensity of internalized (acid-
treated) samples versus total MT1-MMP. Three
representative fields per samplewere used for sta-
tistical analysis. An unpaired Student’s t test was
used to determine statistically significant differ-
ences between untreated and Col I-treated sam-
ples (*, p 0.05; **, p 0.005).
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of MT1-MMP internalization and degradation/turnover for MT1-
CT, as described (41). Col I further activatedMMP-2 in both wtMT1-
MMP- and MT1-CT-transfected cells, and this was not due to
changes in MT1-MMP protein levels (Fig. 8B). ConA can increase
MMP-2 activation via blockade of MT1-MMP internalization (41).
Although ConA activated MMP-2 in wtMT1-MMP-transfected cells,
it was defective in MT1-CT transfected cells, in contrast to Col I
(Fig. 8A). These results confirm that Col I functions through a dif-
ferent mechanism from ConA, independent of the CT-mediated
internalization.
Of the two mechanisms identified for MT1-MMP internalization,
both are dependent on the activity of theGTPase dynamin, whichmedi-
ates the scission from the plasma membrane of both endocytic path-
ways. The activity of dynamin can be inhibited by a dominant negative
form, K44A that is deficient in GTP hydrolysis (42). This dynamin
mutant has been used as a tool to demonstrate thatMT1-MMP is inter-
nalized via a dynamin-mediated pathway (26, 41).When the dominant-
negative K44A mutant was co-transfected with MT1-MMP in MCF-7
cells, basal MMP-2 activation was increased compared with the vector
control/MT1-MMP or wild type dynamin/MT1-MMP co-transfec-
tants (Fig. 9A), as previously observed (26, 41). However, no further
MMP-2 activation in response to Col I was seen in the K44A dynamin/
MT1-MMP co-transfectants, but furtherMMP-2 activationwas seen in
the vector control/wtMT1-MMPorwild type dynamin/MT1-MMPco-
transfectants (Fig. 9A). The total protein levels of MT1-MMP did not
change significantly in all treatments (Fig. 9B). Fig. 9C illustrates that
wild type dynamin and K44A dynamin were expressed to similar levels
(and not expressed in vector control cells), and these levels were slightly
increased in response to Col I. Impairment of MT1-MMP internaliza-
tion using the K44A dominant-negative mutant was also confirmed by
immunofluorescence. Less basal internalizedMT1-MMPwas observed
in the K44A dynamin/MT1-MMP co-transfectants compared with the
wild type dynamin/MT1-MMP co-transfectants (Fig. 9D), confirming
that the K44A mutant is functional in blocking dynamin-mediated
internalization. This suggests that Col I functions by blocking MT1-
MMP internalization in a dynamin-mediated mechanism that was
mimicked by expression of the K44A dominant-negative mutant. Col I
could therefore not further activate MMP-2 in the presence of K44A
dynamin.
Col I Blocks MT1-MMP Internalization via Clathrin-coated Pits—In
order to distinguish which endocytic pathway Col I utilizes to impair
MT1-MMP internalization, we first used two cholesterol-binding com-
pounds, nystatin and methyl--cyclodextrin, which interfere with
caveolae-dependent endocytosis without affecting the clathrin-depend-
ent endocytic pathway (43, 44). Fig. 10A illustrates that both com-
pounds increased the basal level of MMP-2 activation in MCF-7 cells
stably transfected with MT1-MMP, similarly to the K44A dominant-
negative dynamin and consistent with caveolae-disrupting agents, to
impair basalMT1-MMP internalization (24, 26). However, Col I further
increased MMP-2 activation in the presence of nystatin or methyl--
cyclodextrin treatment (Fig. 10A), indicating that Col I does not block
the caveolin-mediated pathway. Interestingly, with the nystatin treat-
ment, we observed an accumulation of the 45-kDa inactive MT1-MMP
form (Fig. 10B), suggesting that the 45-kDa form is normally internal-
FIGURE 8. Col I-inducedMMP-2 activationmechanism differs from ConA.MCF-7 cells were transiently transfected with vector control, wtMT1-MMP, or MT1-CT. The following
day, cells were incubated for 24 h in serum-freemediawith 100 ng/ml rMMP-2 containing 100g/ml Col I or ConA (20g/ml) where indicated.A, conditionedmediumwas analyzed
bygelatin zymography forMMP-2 analysis;B, cell lysateswere analyzedbyWesternblot forMT1-MMPusing theAB815polyclonalMT1-MMPantibody. Pro-MMP-2 (pro), intermediate
active MMP-2 (inter), and fully active MMP-2 (active) are indicated by arrows. The percentage of active MMP-2 (active/total) calculated by densitometry of gelatinolytic bands is
indicated below each zymogram lane. MCF-7 cells transfectedwith vector control (C), wtMT1-MMP (D), or MT1-CT (E) were analyzed 48 h after transfection by immunofluorescence
for cell surface localization of MT1-MMP (green) using the AB815 polyclonal MT1-MMP antibody. Nuclei were stained with propidium iodide (red).
Collagen BlocksMT1-MMP Internalization Independent of CT
MARCH 10, 2006•VOLUME 281•NUMBER 10 JOURNAL OF BIOLOGICAL CHEMISTRY 6835
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
ized via caveolae. The 45-kDa form is not normally seen in these cells
stably transfected with MT1-MMP. Less internalized MT1-MMP was
observed in nystatin-treated cells compared with untreated cells (Fig.
10C), confirming that nystatinwas bioactive, blocking basalMT1-MMP
internalization.
In order to study the involvement of the clathrin-coated pit-me-
diated internalization pathway, we used an Eps1595/295 construct
that functions as a dominant-negative inhibitor to specifically block
Eps15, a crucial component of clathrin-mediated endocytosis, with-
out interfering with clathrin-independent endocytosis (45, 46). By
transiently co-transfecting wtMT1-MMP and Eps1595/295 into
MCF-7 cells, we saw no further increase in MMP-2 activation in
response to Col I; however, increased MMP-2 activation was seen in
response to Col I in vector control/wtMT1-MMP cotransfectants
(Fig. 10D). No differences in total MT1-MMP protein levels were
observed (Fig. 10E). Fig. 10F confirms the co-expression of the green
fluorescent protein-tagged Eps1595/295 mutant protein (green)
with MT1-MMP (red). The specificity of the Eps1595/295 con-
struct for the clathrin-mediated pathway was confirmed, since
Eps1595/295 blocked the internalization of the transferrin receptor
(Fig. 10, G–J), a cell surface molecule known to be internalized via
clathrin-coated pits (46). Note that no red labeled internalized trans-
ferrin is seen in Eps1595/295-expressing cells (green) but that
internalized transeferrin is seen in neighboring cells lacking
Eps1595/295 expression (Fig. 10J) or in vector control-expressing
cells (Fig. 10I). These data thus indicate that Col I functions to block
MT1-MMP internalization via the clathrin-coated pit-mediated
pathway.
DISCUSSION
Col I is often encountered by cells migrating into a stromal environ-
ment and, as such, is an important physiological regulator of MT1-
MMP activity and, consequently,MMP-2 activation.MT1-MMP also is
essential for fine tuning of deposited collagen by connective tissue cells,
as evidenced by thewidespread fibrosis evident inMT1-MMP-deficient
mice (12). 1-containing integrins are the major cell surface receptors
that are required for MMP-2 activation in response to Col I (47). Col I
can increaseMT1-MMP activity by a transcriptional and/or a nontran-
scriptional response. The latter may be a more suitable level of regula-
tion if rapid proteolytic activity is required. The nontranscriptional
component in response toCol I inMCF-7 cells has also been observed in
endothelial cells expressing endogenous MT1-MMP (34). This
response is very rapid, observed within hours of stimulation with Col I,
andmay have evolved alongside the transcriptional response, cooperat-
FIGURE 9. Col I-mediated MMP-2 activation mechanism is dynamin-dependent. MCF-7 cells were co-transfected with wtMT1-MMP and either vector control, wild type (wt)
dynamin (dyn), or dominant-negativeK44Adynamin. The followingday, cellswere incubated for 24h in serum-freemediumwith100ng/ml rMMP-2containing100g/mlCol Iwhere
indicated. A, conditioned mediumwas analyzed by gelatin zymography for MMP-2 analysis. B, cell lysates were analyzed by Western blot for MT1-MMP using the AB815 polyclonal
antibody; C, RNA was collected for dynamin quantitative RT-PCR. Pro-MMP-2 (pro), intermediate active MMP-2 (inter), and fully active MMP-2 (active) are indicated by arrows. The
percentage of active MMP-2 (active/total) calculated by densitometry of gelatinolytic bands is indicated below each zymogram lane. D, for internalization analysis, MCF-7 cells
co-transfected with wtMT1-MMP and wild type dynamin or wtMT1-MMP and K44A dynamin were equilibrated at 4 °C, and the cells were incubated with the AB815 polyclonal
MT1-MMP antibody at 4 °C and thenwarmed to 37 °C for 0 or 20min. Cells were then left untreated or treatedwith acetic acid at 4 °C, washedwith PBS, fixed, and permeabilized, and
primary antibodywasdetectedwith a secondaryAlexa Fluor 488 antibody. Thepercentageof internalizedMT1-MMPwasdeterminedbymeasuring thepixel intensity of internalized
(acid-treated) samples versus totalMT1-MMP. Three representative fields per samplewere used for statistical analysis. An unpaired Student’s t test was used to determine statistically
significant differences between untreated and Col I-treated samples (*, p 0.05).
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ing for both rapid and sustained proteolytic activity. A similar nontran-
scriptional component of MMP-2 activation via MT1-MMP has been
observed in U87 glioma cells in response to cytochalasin D (48) and in
MDA-MB-231 breast cancer cells in response to ConA (49). In the
nontranscriptional response of MMP-2 activation inMCF-7 cells, Col I
blocked the internalization of MT1-MMP in a dynamin- and clathrin-
dependent fashion, leading to increased MMP-2 activation, and caused
a redistribution of MT1-MMP to the cell periphery. In contrast
to ConA-induced MMP-2 activation, Col I effects on MT1-MMP
internalization were independent of the TM/CT domains.
FIGURE 10. Col I-mediated MMP-2 activation mechanism is dependent on clathrin-coated pits. MCF-7 cells stably transfected with wtMT1-MMP (MCF-7-MT1-MMP) were
incubated in serum-freemediumwith100ng/ml rMMP-2,withorwithout30g/mlnystatinor 5mMmethyl--cyclodextrin for several hours. Cellswere theneither treatedornotwith
100g/ml Col I where indicated for 24 h.A, conditionedmediumwas analyzed by gelatin zymography forMMP-2 analysis; B, cell lysateswere analyzed byWestern blot forMT1-MMP
using theAB815 polyclonalMT1-MMPantibody. Pro-MMP-2 (pro), intermediate activeMMP-2 (inter), and fully activeMMP-2 (active) are indicated by arrows. The percentage of active
MMP-2 (active/total) calculated by densitometry of gelatinolytic bands is indicated below each zymogram lane.C, for internalization studies,MCF-7-MT1-MMP cells were treatedwith
30g/ml nystatinwhere indicated for 24h. Cellswere thenequilibrated at 4 °C, and cell surfaceMT1-MMPwas labeledwith theAB815polyclonalMT1-MMPantibody at 4 °C and then
warmed to 37 °C for 0 or 20min. Cells were then left untreated or treatedwith acetic acid at 4 °C, washedwith PBS, fixed, and permeabilized, and primary antibodywas detectedwith
a secondary Alexa Fluor 488 antibody. The percentage of internalizedMT1-MMPwas determined bymeasuring the pixel intensity of internalized (acid-treated) samples versus total
MT1-MMP. Three representative fields per sample were used for statistical analysis. An unpaired Student’s t test was used to determine statistically significant differences between
untreated and nystatin-treated samples (*, p 0.05). MCF-7 cells were co-transfected with wtMT1-MMP and either vector control or Eps1595/295. The following day, cells were
incubated for 24 h in serum-free medium with 100 ng/ml rMMP-2 containing 100 g/ml Col I where indicated. D, conditioned medium was analyzed by gelatin zymography for
MMP-2 analysis; E, cell lysates were analyzed by Western blot for MT1-MMP, using the AB815 polyclonal MT1-MMP antibody. Cells expressing Eps1595/295 (pEGFP) are shown as
green, andMT1-MMP is shown in red (F). Internalized transferrin was detected by incubatingMCF-7 cells transiently transfectedwith Eps1595/295 (H and J) or pEGFP vector control
(G and I) with no transferrin (G and H) or 25 g/ml Alexa Fluor 568-conjugated transferrin (I and J) for 30 min at 37 °C. Cells were then treated with acetic acid for 10 min at 4 °C.
Internalized transferrin appears as red, whereas Eps1595/295 or pEGFP vector expression is green.
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Important Functional Domains of MT1-MMP—MT1-MMP con-
tains several domains that are required for proper function and local-
ization of the enzyme.Membrane anchorage ofMT1-MMP through the
TM domain is essential for proper localization and function of the
enzyme, including MMP-2 activation (37, 50). The CAT domain is also
essential for proteolytic activity, since it contains the catalytic active site.
Oligomerization via the HPX domain has been shown to be important
to keepMT1-MMPmolecules in close proximity, an important require-
ment for MMP-2 activation (21, 22). The HPX domain of MT1-MMP
can directly bind native Col I, and it has been suggested that Col I may
assemble MT1-MMP on the cell surface through binding to the HPX
domain, resulting in an increase in the local concentration of MT1-
MMP for collagenolysis and MMP-2 activation (28). It was also found
that recombinant solubleMT1-MMPHPX/hinge domain inhibited Col
I-induced MMP-2 activation in human gingival fibroblasts cultured in
three-dimensional collagen gels (28). Tam et al. (28) proposed that sol-
uble MT1-MMP HPX/hinge blocked Col I-induced MMP-2 activation
via competitive binding for Col I between the exogenous HPX/hinge
and endogenous wtMT1-MMP rather than competitively disrupting
MT1-MMP/MT1-MMP binding interactions. This clustering activity
may indeed be an alternate mechanism to increase MT1-MMP activity
in certain cell types, although it is unlikely that it occurs in our cell
system, since it is not supported by our internalization results.
Internalization of MT1-MMP—MT1-MMP can be internalized by
two distinct pathways: clathrin-coated pit-mediated internalization (25,
26) and clathrin-independent mechanisms involving caveolae (24, 26)
(illustrated in Fig. 11). Studies usingMT1-MMP deletion mutants lack-
ing the CT have shown that the CT is not required for basal MMP-2
activation (37, 38), as confirmed in our studies.However, theCT tail was
critical for MT1-MMP localization to invadopodia or the leading edge
of migrating cells, ECM degradation, and cell migration and invasion
(38, 50). The region of the CT required for these responses was defined
as between Thr567 and Ser577 (50). Uekita et al. (25) have further shown
by mutation studies that dileucine residues Leu571-Leu572 and Leu578-
Leu579 as well as Tyr573 in the CT of MT1-MMP were critical for its
internalization under basal conditions. Furthermore, MT1-MMP was
found to co-localize with clathrin-coated pits, and the 2 subunit of
adaptor protein 2 (AP-2), a component of clathrin-coated pits, was
shown to bind to the LLY573 sequence of the CT of MT1-MMP (25).
ConA can induceMMP-2 activation post-translationally by blocking
MT1-MMP internalization via clathrin-coated pits (41). Under basal
conditions, MT1-CT was more effective at activating MMP-2 than
wtMT1-MMP and showed increased cell surface expression compared
with wtMT1-MMP, due to the removal of the internalization signals in
the CT (41). MMP-2 activation viaMT1-CTwas found to be resistant
to ConA treatment (41), as also observed in our studies, suggesting that
ConA regulatesMT1-MMP activity throughCT-dependent trafficking.
Nevertheless, Col I activated MMP-2 via the MT1-CT mutant, illus-
trating that Col I and ConA block MT1-MMP internalization through
two distinct mechanisms, one involving the CT (ConA) and one that
FIGURE 11.Model of Col I-induced MMP-2 activation. Basal MT1-MMP internalization from the cell surface involves both clathrin-coated pit-mediated mechanisms and clathrin-
independent mechanisms involving caveolae, both of which aremediated by theMT1-MMP CT. A third non-CT-mediatedMT1-MMP internalizationmechanism has been identified
via CD63. Col I blocks MT1-MMP internalization through a mechanism involving the HPX domain. We suggest that Col I induces the association of the HPX domain of cell surface
MT1-MMP with another molecule (possibly CD63 or another transmembrane protein, such as 1 integrin), which in turn leads to internalization of this complex via clathrin-coated
pits. Nystatin is an inhibitor of internalization mechanisms involving caveolae, whereas Eps1595/295 blocks clathrin-mediated endocytosis. Dynamin K44A blocks both caveolae
and clathrin-mediated endocytic pathways.
Collagen BlocksMT1-MMP Internalization Independent of CT
6838 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 10•MARCH 10, 2006
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
does not (Col I). Furthermore, although a direct impairment of basal
MT1-MMP internalization was observed using MT1-CT, further
inhibition of internalization was observed after treatment with Col I,
again indicating that Col I blocksMT1-MMP internalization independ-
ent of signals in the CT. Taken together, since Col I impaired the inter-
nalization of wtMT1-MMP, MT1-CAT, and MT1-CT, and
increased cell surface expression was observed in response to Col I for
MT1-IL2R but not MT1-HPX, these data indicate that the Col I reg-
ulatory region lies in the MT1-MMP HPX domain.
Dynamin is aGTPase implicated in endocytosis bymediating scission
of newly formed vesicles from the plasma membrane of both clathrin-
coated pits and caveolae (51). Our results using dominant-negative
K44A dynamin indicate that this mutant blocks MT1-MMP endocyto-
sis, resulting in increased basal MMP-2 activation, as also previously
seen (25, 26, 41). However Col I could not further activate MMP-2,
presumably because internalization had already been blocked by the
K44A dynamin. Our results demonstrate that Col I blocks the dynamin-
dependent internalization of MT1-MMP.
Caveolae are flask-shaped cholesterol-rich microdomains on or near
the cell surface involved in internalization of cell surface receptors, recy-
cling of molecules via the Golgi, and signal transduction pathways (52).
Caveolae were found as the major MT1-MMP endocytic pathway in
endothelial cells, and caveolae-disrupting agents or small interfering
RNA toward caveolin-1 impaired MT1-MMP internalization, cell sur-
face localization at clusters, activity, and function inmigrating endothe-
lial cells. Col I, however, blocked this caveolae-mediated pathway
through the action of Rho A (24). Despite this report, the caveolae
pathway was not involved in Col I-mediated inhibition of MT1-MMP
internalization in the nontranscriptional component in MCF-7 cells,
illustrating that different mechanisms exist in different cell types.
Clathrin-coated vesicles are a major pathway for receptor-mediated
endocytosis. Many protein constituents make up clathrin-coated vesi-
cles, including AP-2 adapter protein, clathrin, dynamin, and Eps15 (epi-
dermal growth factor receptor pathway substrate clone 15) (53). An
Eps15 dominant-negative mutant that lacks two of the three Eps15
homology domains (Eps1595/295) has been useful in the study of
endocytic pathways involving clathrin-coated pits (46) and has deter-
mined that Col I specifically blocks MT1-MMP endocytosis via the
clathrin-mediated pathway in MCF-7 cells. However, Col I does not
function as a general inhibitor of endocytosis, since internalization of
the transferrin receptor, a well defined marker of clathrin-coated pit
endocytosis, was not affected by Col I treatment (data not shown).
Similarly to our results, endothelial cells cultured on1 integrin ECM
substrates such as Col I, fibronectin, or fibrinogen displayed impaired
internalization of MT1-MMP compared with non-1 integrin ECM
substrates (34). Furthermore, co-immunoprecipitation assays demon-
strated a biochemical association between MT1-MMP and 1 and v
integrins when endothelial cells were cultured on Col I (34). It was
hypothesized that clustering of1 integrins induced phosphorylation or
recruitment of cytoskeletal/signaling molecules that could interfere
withMT1-MMP endocytosis. Additionally, physical retention of MT1-
MMP through interactions with1 orv3 at the cell membrane could
blockMT1-MMP internalization (34). As hypothesized by Galvez et al.
(34), it is possible that Col I interferes with MT1-MMP internalization
in MCF-7 cells by inducing a physical association between the MT1-
MMP HPX domain and 1 integrin, thereby overriding the non-CT-
mediated internalization signals, keeping MT1-MMP on the cell sur-
face. Another candidate molecule that may regulate the internalization
of MT1-MMP via Col I is the tetraspanin CD63. It was recently identi-
fied that a third MT1-MMP endocytic pathway existed involving the
MT1-MMP ectodomain. CD63 formed a complex on the cell surface
with the MT1-MMP HPX domain, thereby promoting endocytosis of
this complex via internalization signals in the CT of CD63 into lyso-
somes targeted for degradation (54). Taken together, our results may
support the hypothesis that Col I induces MMP-2 activation through
specific inhibition of the CD63-mediated mechanism of MT1-MMP
endocytosis involving clathrin-coated pits (Fig. 11). Studies are ongoing
to test this hypothesis. Finally, Wu et al. (55) have shown that focal
adhesion kinase/Src-mediated phosphorylation of endophilin A2 pre-
vented endophilin A2 from associating with dynamin, thereby blocking
MT1-MMP endocytosis. Considering that focal adhesion kinase can be
activated upon integrin ligation, it is tempting to speculate that Col I
signaling via Col I-binding integrins feeds into the above mentioned
pathway to block MT1-MMP endocytosis via focal adhesion kinase/
Src-mediated phosphorylation of endophilin A2.
In conclusion, we have further elucidated the mechanism of the non-
transcriptional component ofMMP-2 activation in response toCol I, an
important physiological activator of MMP-2 often found surrounding
tumors. We identified that Col I impairs MT1-MMP internalization,
thereby providing a rapid mechanism to increase MMP-2 activation
through a dynamin- and clathrin-mediated mechanism involving the
HPX domain of MT1-MMP. In addition, Col I induced a redistribution
of preexisting cell surfaceMT1-MMPmolecules to the periphery of the
cells. Specifically targeting these various components of the MMP-2
activation mechanism may offer novel strategies to limit proteolytic
activity required for tumor growth, invasion, and metastasis.
Acknowledgment—We thank Tony Blick for the design of primers for quanti-
tative RT-PCR analysis.
REFERENCES
1. Egeblad, M., and Werb, Z. (2002) Nat. Rev. Cancer 2, 161–174
2. Lafleur, M. A., Handsley, M. M., and Edwards, D. R. (2003) Expert Rev. Mol. Med. 5,
1–39
3. Overall, C. M., and Lopez-Otin, C. (2002) Nat. Rev. Cancer 2, 657–672
4. Noel, A. C., Polette,M., Lewalle, J.M.,Munaut, C., Emonard, H. P., Birembaut, P., and
Foidart, J. M. (1994) Int. J. Cancer 56, 331–336
5. Dalberg, K., Eriksson, E., Enberg, U., Kjellman, M., and Backdahl, M. (2000) World
J. Surg. 24, 334–340
6. Belkin, A. M., Akimov, S. S., Zaritskaya, L. S., Ratnikov, B. I., Deryugina, E. I., and
Strongin, A. Y. (2001) J. Biol. Chem. 276, 18415–18422
7. Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., and Seiki, M. (2001)
J. Cell Biol. 153, 893–904
8. Deryugina, E. I., Ratnikov, B. I., Postnova, T. I., Rozanov, D. V., and Strongin, A. Y.
(2002) J. Biol. Chem. 277, 9749–9756
9. Tam, E. M., Morrison, C. J., Wu, Y. I., Stack, M. S., and Overall, C. M. (2004) Proc.
Natl. Acad. Sci. U. S. A. 101, 6917–6922
10. Seiki, M., Koshikawa, N., and Yana, I. (2003) Cancer Metastasis Rev. 22, 129–143
11. Hotary, K., Allen, E., Punturieri, A., Yana, I., and Weiss, S. J. (2000) J. Cell Biol. 149,
1309–1323
12. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A.,
Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I., Ward, J. M., and Birkedal-Hansen,
H. (1999) Cell 99, 81–92
13. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R.W.,Wang, J., Cao,
Y., and Tryggvason, K. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 4052–4057
14. Oh, J., Takahashi, R., Adachi, E., Kondo, S., Kuratomi, S., Noma, A., Alexander, D. B.,
Motoda, H., Okada, A., Seiki, M., Itoh, T., Itohara, S., Takahashi, C., and Noda, M.
(2004) Oncogene 23, 5041–5048
15. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg,
G. I. (1995) J. Biol. Chem. 270, 5331–5338
16. Butler, G. S., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., van Westrum, S. S.,
Crabbe, T., Clements, J., d’Ortho, M. P., and Murphy, G. (1998) J. Biol. Chem. 273,
871–880
17. Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y., and Seiki,M. (1998)
J. Biol. Chem. 273, 16098–16103
18. Atkinson, S. J., Crabbe, T., Cowell, S., Ward, R. V., Butler, M. J., Sato, H., Seiki, M.,
Reynolds, J. J., and Murphy, G. (1995) J. Biol. Chem. 270, 30479–30485
Collagen BlocksMT1-MMP Internalization Independent of CT
MARCH 10, 2006•VOLUME 281•NUMBER 10 JOURNAL OF BIOLOGICAL CHEMISTRY 6839
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
19. Sato, H., Takino, T., Kinoshita, T., Imai, K., Okada, Y., Stetler Stevenson, W. G., and
Seiki, M. (1996) FEBS Lett. 385, 238–240
20. Wu, Y. I., Munshi, H. G., Sen, R., Snipas, S. J., Salvesen, G. S., Fridman, R., and Stack,
M. S. (2004) J. Biol. Chem. 279, 8278–8289
21. Itoh, Y., Takamura, A., Ito, N., Maru, Y., Sato, H., Suenaga, N., Aoki, T., and Seiki, M.
(2001) EMBO J. 20, 4782–4793
22. Lehti, K., Lohi, J., Juntunen,M.M., Pei, D., and Keski-Oja, J. (2002) J. Biol. Chem. 277,
8440–8448
23. Rozanov, D. V., Deryugina, E. I., Ratnikov, B. I., Monosov, E. Z., Marchenko, G. N.,
Quigley, J. P., and Strongin, A. Y. (2001) J. Biol. Chem. 276, 25705–25714
24. Galvez, B. G., Matias-Roman, S., Yanez-Mo, M., Vicente-Manzanares, M., Sanchez-
Madrid, F., and Arroyo, A. G. (2004)Mol. Biol. Cell 15, 678–687
25. Uekita, T., Itoh, Y., Yana, I., Ohno,H., and Seiki,M. (2001) J. Cell Biol.155, 1345–1356
26. Remacle, A., Murphy, G., and Roghi, C. (2003) J. Cell Sci. 116, 3905–3916
27. Ruangpanit, N., Chan, D., Holmbeck, K., Birkedal-Hansen, H., Polarek, J., Yang, C.,
Bateman, J. F., and Thompson, E. W. (2001)Matrix Biol. 20, 193–203
28. Tam, E. M., Wu, Y. I., Butler, G. S., Stack, M. S., and Overall, C. M. (2002) J. Biol.
Chem. 277, 39005–39014
29. Azzam, H. S., Arand, G., Lippman,M. E., and Thompson, E.W. (1993) J. Natl. Cancer
Inst. 85, 1758–1764
30. Nguyen, M., Arkell, J., and Jackson, C. J. (2000) Int. J. Biochem. Cell Biol. 32, 621–631
31. Takino, T., Miyamori, H., Watanabe, Y., Yoshioka, K., Seiki, M., and Sato, H. (2004)
Cancer Res. 64, 1044–1049
32. Haas, T. L., Stitelman, D., Davis, S. J., Apte, S. S., andMadri, J. A. (1999) J. Biol. Chem.
274, 22679–22685
33. Zhuge, Y., and Xu, J. (2001) J. Biol. Chem. 276, 16248–16256
34. Galvez, B. G., Matias-Roman, S., Yanez-Mo, M., Sanchez-Madrid, F., and Arroyo,
A. G. (2002) J. Cell Biol. 159, 509–521
35. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. W. (1997) Lab.
Invest. 76, 651–660
36. Gilles, C., Bassuk, J. A., Pulyaeva, H., Sage, E. H., Foidart, J. M., and Thompson, E. W.
(1998) Cancer Res. 58, 5529–5536
37. Cao, J., Sato, H., Takino, T., and Seiki, M. (1995) J. Biol. Chem. 270, 801–805
38. Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., and Chen,
W. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 7959–7964
39. Wang, P., Nie, J., and Pei, D. (2004) J. Biol. Chem. 279, 51148–51155
40. Lemmon, M. A., and Schlessinger, J. (1994) Trends Biochem. Sci. 19, 459–463
41. Jiang, A., Lehti, K., Wang, X., Weiss, S. J., Keski-Oja, J., and Pei, D. (2001) Proc. Natl.
Acad. Sci. U. S. A. 98, 13693–13698
42. Cao,H., Thompson,H.M., Krueger, E.W., andMcNiven,M.A. (2000) J. Cell Sci. 113,
1993–2002
43. Schnitzer, J. E., Liu, J., and Oh, P. (1995) J. Biol. Chem. 270, 14399–14404
44. Deckert, M., Ticchioni, M., and Bernard, A. (1996) J. Cell Biol. 133, 791–799
45. Brodsky, F. M., Chen, C. Y., Knuehl, C., Towler, M. C., and Wakeham, D. E. (2001)
Annu. Rev. Cell Dev. Biol. 17, 517–568
46. Benmerah, A., Bayrou, M., Cerf-Bensussan, N., and Dautry-Varsat, A. (1999) J. Cell
Sci. 112, 1303–1311
47. Ellerbroek, S. M., Fishman, D. A., Kearns, A. S., Bafetti, L. M., and Stack, M. S. (1999)
Cancer Res. 59, 1635–1641
48. Gingras, D., Page, M., Annabi, B., and Beliveau, R. (2000) Biochim. Biophys. Acta
1497, 341–350
49. Yu, M., Sato, H., Seiki, M., and Thompson, E. W. (1995) Cancer Res. 55, 3272–3277
50. Lehti, K., Valtanen, H., Wickstrom, S., Lohi, J., and Keski-Oja, J. (2000) J. Biol. Chem.
275, 15006–15013
51. Henley, J. R., Cao, H., and McNiven, M. A. (1999) FASEB J. 13, Suppl. 2, 243–247
52. Carver, L. A., and Schnitzer, J. E. (2003) Nat. Rev. Cancer 3, 571–581
53. Mousavi, S. A., Malerod, L., Berg, T., and Kjeken, R. (2004) Biochem. J. 377, 1–16
54. Takino, T., Miyamori, H., Kawaguchi, N., Uekita, T., Seiki, M., and Sato, H. (2003)
Biochem. Biophys. Res. Commun. 304, 160–166
55. Wu, X., Gan, B., Yoo, Y., and Guan, J. L. (2005) Dev. Cell 9, 185–196
Collagen BlocksMT1-MMP Internalization Independent of CT
6840 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 10•MARCH 10, 2006
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Sato and Erik W. Thompson
Marc A. Lafleur, Francesca A. Mercuri, Neeracha Ruangpanit, Motoharu Seiki, Hiroshi
Domain
Type 1 Matrix Metalloproteinase (MT1-MMP) via the MT1-MMP Hemopexin 
Type I Collagen Abrogates the Clathrin-mediated Internalization of Membrane
doi: 10.1074/jbc.M513084200 originally published online December 28, 2005
2006, 281:6826-6840.J. Biol. Chem. 
  
 10.1074/jbc.M513084200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/281/10/6826.full.html#ref-list-1
This article cites 55 references, 35 of which can be accessed free at
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
